Large-scale testing (Phase 3)Study completedNCT00004941
What this trial is testing
Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease
Who this might be right for
Crohn's Disease
FDA Office of Orphan Products Development 94